Table 1.

Study data sets for malignant and benign class distribution [21]. Set A (n=1094): training and validation set; set B (n=607): testing set.

Tumor type	Set A, n (%)	Set B, n (%)
Malignant	634 (58)	508 (83.7)
Benign	460 (42)	99 (16.3)